Delisting riskPopularity #5,097
AIDX · NASDAQ · Medical - Care Facilities

20/20 Biolabs (AIDX)

Blood testing for cancer screening and inflammation tracking, plus laboratory services for diagnostic developers.

$0.4520
After hours−0.02 (−3.93%)
At close$0.4705(+0.13%)